Are Improvements in Cognitive Content and Depressive Symptoms Correlates or Mediators during Acute-Phase Cognitive Therapy for Recurrent Major Depressive Disorder?

被引:17
|
作者
Vittengl, Jeffrey R. [1 ]
Clark, Lee Anna [2 ]
Thase, Michael E. [3 ]
Jarrett, Robin B. [4 ]
机构
[1] Truman State Univ, Dept Psychol, Kirksville, MO 63501 USA
[2] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA
[3] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
[4] Univ Texas Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA
来源
关键词
Cognitive therapy; major depressive disorder; cognitive content; mediation; DSM-IV DISORDERS; SELF-CONTROL; LEARNED RESOURCEFULNESS; BEHAVIORAL THERAPY; DYSFUNCTIONAL ATTITUDES; AUTOMATIC THOUGHTS; RANDOMIZED-TRIAL; NORMATIVE DATA; SUDDEN GAINS; MISSING DATA;
D O I
10.1521/ijct.2014.7.3.251
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The cognitive model of depression posits that cognitive therapy's (CT) effect on depressive symptoms is mediated by changes in cognitive content (e.g., automatic negative thoughts, dysfunctional attitudes, failure attributions). We tested improvement and normalization of cognitive content among outpatients (N = 523) with recurrent major depressive disorder treated with acute-phase CT (Jarrett & Thase, 2010; Jarrett, Minhajuddin, Gershenfeld, Friedman, & Thase, 2013). We also tested whether improvement in cognitive content accounted for subsequent changes in depressive symptoms and vice versa. Five measures of content improved substantively from pre- to post-CT (median d = 0.96), and the proportions of patients scoring in "healthy" ranges increased (median 45% to 82%). Evidence for cognitive mediation of symptom reduction was limited (median r = .06), as was evidence for symptom mediation of cognitive content improvement (median r = .07). We discuss measurement and design issues relevant to detection of mediators and consider alternative theories of change.
引用
收藏
页码:251 / 271
页数:21
相关论文
共 50 条
  • [21] Effects of vortioxetine on cognitive symptoms of major depressive disorder (MDD)
    Fava, M.
    Lophaven, S.
    Olsen, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 61 - 61
  • [22] Italian neurologists' perception on cognitive symptoms in major depressive disorder
    Neri, G.
    Serrati, C.
    Zolo, P.
    Cataldo, N.
    Ripellino, C.
    NEUROLOGICAL SCIENCES, 2016, 37 (09) : 1437 - 1442
  • [23] Cognitive impairment in major depressive disorder
    Pan, Zihang
    Park, Caroline
    Brietzke, Elisa
    Zuckerman, Hannah
    Rong, Carola
    Mansur, Rodrigo B.
    Fus, Dominika
    Subramaniapillai, Mehala
    Lee, Yena
    McIntyre, Roger S.
    CNS SPECTRUMS, 2019, 24 (01) : 22 - 29
  • [24] Cognitive dysfunction in major depressive disorder
    Knight, Matthew J.
    Baune, Bernhard T.
    CURRENT OPINION IN PSYCHIATRY, 2018, 31 (01) : 26 - 31
  • [25] Cognitive Hypnotherapy for Major Depressive Disorder
    Alladin, Assen
    AMERICAN JOURNAL OF CLINICAL HYPNOSIS, 2012, 54 (04) : 275 - 293
  • [26] Major depressive disorder and cognitive impairment
    McIntyre, Roger S.
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2014, 39 (05): : E36 - E37
  • [27] Fluoxetine plus cognitive behavioural therapy improves symptoms of major depressive disorder in adolescents
    March, J.
    Silva, S.
    Petrycki, S.
    EVIDENCE-BASED MENTAL HEALTH, 2005, 8 (01) : 10 - 10
  • [28] iNOS gene expression correlates with cognitive impairment in recurrent depressive disorder
    Talarowska, M.
    Galecki, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S327 - S328
  • [29] The effects of cognitive reserve and depressive symptoms on cognitive performance in major depression and bipolar disorder
    Ponsoni, Andre
    Branco, Laura Damiani
    Cotrena, Charles
    Shansis, Flavio Milman
    Fonseca, Rochele Paz
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 274 : 813 - 818
  • [30] Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression
    Vittengl, JR
    Clark, LA
    Kraft, D
    Jarrett, RB
    PSYCHOLOGICAL MEDICINE, 2005, 35 (05) : 693 - 704